001     147186
005     20240229123021.0
024 7 _ |a 10.1093/ije/dyz193
|2 doi
024 7 _ |a pmid:31605532
|2 pmid
024 7 _ |a 0300-5771
|2 ISSN
024 7 _ |a 1464-3685
|2 ISSN
024 7 _ |a altmetric:68296786
|2 altmetric
037 _ _ |a DKFZ-2019-02322
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Kapoor, Pooja Middha
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium.
260 _ _ |a Oxford
|c 2020
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1636632163_5417
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Feb 1;49(1):216-232#EA:C020#
520 _ _ |a Previous gene-environment interaction studies of breast cancer risk have provided sparse evidence of interactions. Using the largest available dataset to date, we performed a comprehensive assessment of potential effect modification of 205 common susceptibility variants by 13 established breast cancer risk factors, including replication of previously reported interactions.Analyses were performed using 28 176 cases and 32 209 controls genotyped with iCOGS array and 44 109 cases and 48 145 controls genotyped using OncoArray from the Breast Cancer Association Consortium (BCAC). Gene-environment interactions were assessed using unconditional logistic regression and likelihood ratio tests for breast cancer risk overall and by estrogen-receptor (ER) status. Bayesian false discovery probability was used to assess the noteworthiness of the meta-analysed array-specific interactions.Noteworthy evidence of interaction at ≤1% prior probability was observed for three single nucleotide polymorphism (SNP)-risk factor pairs. SNP rs4442975 was associated with a greater reduction of risk of ER-positive breast cancer [odds ratio (OR)int = 0.85 (0.78-0.93), Pint = 2.8 x 10-4] and overall breast cancer [ORint = 0.85 (0.78-0.92), Pint = 7.4 x 10-5) in current users of estrogen-progesterone therapy compared with non-users. This finding was supported by replication using OncoArray data of the previously reported interaction between rs13387042 (r2 = 0.93 with rs4442975) and current estrogen-progesterone therapy for overall disease (Pint = 0.004). The two other interactions suggested stronger associations between SNP rs6596100 and ER-negative breast cancer with increasing parity and younger age at first birth.Overall, our study does not suggest strong effect modification of common breast cancer susceptibility variants by established risk factors.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Lindström, Sara
|b 1
700 1 _ |a Behrens, Sabine
|0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
|b 2
700 1 _ |a Wang, Xiaoliang
|b 3
700 1 _ |a Michailidou, Kyriaki
|b 4
700 1 _ |a Bolla, Manjeet K
|b 5
700 1 _ |a Wang, Qin
|b 6
700 1 _ |a Dennis, Joe
|b 7
700 1 _ |a Dunning, Alison M
|b 8
700 1 _ |a Pharoah, Paul D P
|b 9
700 1 _ |a Schmidt, Marjanka K
|b 10
700 1 _ |a Kraft, Peter
|b 11
700 1 _ |a García-Closas, Montserrat
|b 12
700 1 _ |a Easton, Douglas F
|b 13
700 1 _ |a Milne, Roger L
|b 14
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 15
700 1 _ |a Consortium, Breast Cancer Association
|b 16
|e Collaboration Author
700 1 _ |a Ahearn, Thomas
|b 17
700 1 _ |a Andrulis, Irene L
|b 18
700 1 _ |a Anton-Culver, Hoda
|b 19
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 20
|u dkfz
700 1 _ |a Aronson, Kristan J
|b 21
700 1 _ |a Auer, Paul L
|b 22
700 1 _ |a Augustinsson, Annelie
|b 23
700 1 _ |a Freeman, Laura E Beane
|b 24
700 1 _ |a Beckmann, Matthias W
|b 25
700 1 _ |a Benitez, Javier
|b 26
700 1 _ |a Bernstein, Leslie
|b 27
700 1 _ |a Berrandou, Takiy
|b 28
700 1 _ |a Bojesen, Stig E
|b 29
700 1 _ |a Brauch, Hiltrud
|b 30
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 31
700 1 _ |a Brock, Ian W
|b 32
700 1 _ |a Broeks, Annegien
|b 33
700 1 _ |a Brooks-Wilson, Angela
|b 34
700 1 _ |a Butterbach, Katja
|0 P:(DE-He78)7ca7eafba864e5c3ebb7598149380452
|b 35
700 1 _ |a Cai, Qiuyin
|b 36
700 1 _ |a Campa, Daniele
|b 37
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 38
700 1 _ |a Carter, Brian D
|b 39
700 1 _ |a Castelao, Jose E
|b 40
700 1 _ |a Chanock, Stephen J
|b 41
700 1 _ |a Chenevix-Trench, Georgia
|b 42
700 1 _ |a Cheng, Ting-Yuan David
|b 43
700 1 _ |a Clarke, Christine L
|b 44
700 1 _ |a Cordina-Duverger, Emilie
|b 45
700 1 _ |a Couch, Fergus J
|b 46
700 1 _ |a Cox, Angela
|b 47
700 1 _ |a Cross, Simon S
|b 48
700 1 _ |a Czene, Kamila
|b 49
700 1 _ |a Dai, James Y
|b 50
700 1 _ |a Dite, Gillian S
|b 51
700 1 _ |a Earp, H Shelton
|b 52
700 1 _ |a Eliassen, A Heather
|b 53
700 1 _ |a Eriksson, Mikael
|b 54
700 1 _ |a Evans, D Gareth
|b 55
700 1 _ |a Fasching, Peter A
|b 56
700 1 _ |a Figueroa, Jonine
|b 57
700 1 _ |a Flyger, Henrik
|b 58
700 1 _ |a Fritschi, Lin
|b 59
700 1 _ |a Gabrielson, Marike
|b 60
700 1 _ |a Gago-Dominguez, Manuela
|b 61
700 1 _ |a Gapstur, Susan M
|b 62
700 1 _ |a Gaudet, Mia M
|b 63
700 1 _ |a Giles, Graham G
|b 64
700 1 _ |a González-Neira, Anna
|b 65
700 1 _ |a Grundy, Anne
|b 66
700 1 _ |a Guénel, Pascal
|b 67
700 1 _ |a Haeberle, Lothar
|b 68
700 1 _ |a Haiman, Christopher A
|b 69
700 1 _ |a Håkansson, Niclas
|b 70
700 1 _ |a Hall, Per
|b 71
700 1 _ |a Hamann, Ute
|0 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
|b 72
700 1 _ |a Hankinson, Susan E
|b 73
700 1 _ |a Harkness, Elaine F
|b 74
700 1 _ |a Harstad, Tricia
|b 75
700 1 _ |a He, Wei
|b 76
700 1 _ |a Heyworth, Jane
|b 77
700 1 _ |a Hoover, Robert N
|b 78
700 1 _ |a Hopper, John L
|b 79
700 1 _ |a Humphreys, Keith
|b 80
700 1 _ |a Hunter, David J
|b 81
700 1 _ |a Marrón, Pablo Isidro
|b 82
700 1 _ |a John, Esther M
|b 83
700 1 _ |a Jones, Michael E
|b 84
700 1 _ |a Jung, Audrey
|0 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
|b 85
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 86
700 1 _ |a Keeman, Renske
|b 87
700 1 _ |a Kitahara, Cari M
|b 88
700 1 _ |a Ko, Yon-Dschun
|b 89
700 1 _ |a Koutros, Stella
|b 90
700 1 _ |a Krüger, Ute
|b 91
700 1 _ |a Lambrechts, Diether
|b 92
700 1 _ |a Marchand, Loic Le
|b 93
700 1 _ |a Lee, Eunjung
|b 94
700 1 _ |a Lejbkowicz, Flavio
|b 95
700 1 _ |a Linet, Martha
|b 96
700 1 _ |a Lissowska, Jolanta
|b 97
700 1 _ |a Llaneza, Ana
|b 98
700 1 _ |a Lo, Wing-Yee
|b 99
700 1 _ |a Makalic, Enes
|b 100
700 1 _ |a Martinez, Maria Elena
|b 101
700 1 _ |a Maurer, Tabea
|b 102
700 1 _ |a Muñoz-Garzon, Victor M
|b 103
700 1 _ |a Neuhausen, Susan L
|b 104
700 1 _ |a Neven, Patrick
|b 105
700 1 _ |a Newman, William G
|b 106
700 1 _ |a Nielsen, Sune F
|b 107
700 1 _ |a Nordestgaard, Børge G
|b 108
700 1 _ |a Norman, Aaron
|b 109
700 1 _ |a O'Brien, Katie M
|b 110
700 1 _ |a Olshan, Andrew F
|b 111
700 1 _ |a Olson, Janet E
|b 112
700 1 _ |a Olsson, Håkan
|b 113
700 1 _ |a Orr, Nick
|b 114
700 1 _ |a Perou, Charles M
|b 115
700 1 _ |a Pinchev, Mila
|b 116
700 1 _ |a Prentice, Ross
|b 117
700 1 _ |a Rennert, Gad
|b 118
700 1 _ |a Rennert, Hedy S
|b 119
700 1 _ |a Ruddy, Kathryn J
|b 120
700 1 _ |a Sandler, Dale P
|b 121
700 1 _ |a Schneider, Michael O
|b 122
700 1 _ |a Schoemaker, Minouk J
|b 123
700 1 _ |a Schöttker, Ben
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 124
|u dkfz
700 1 _ |a Scott, Rodney J
|b 125
700 1 _ |a Scott, Christopher
|b 126
700 1 _ |a Sherman, Mark E
|b 127
700 1 _ |a Shrubsole, Martha J
|b 128
700 1 _ |a Shu, Xiao-Ou
|b 129
700 1 _ |a Southey, Melissa C
|b 130
700 1 _ |a Spinelli, John J
|b 131
700 1 _ |a Stone, Jennifer
|b 132
700 1 _ |a Swerdlow, Anthony J
|b 133
700 1 _ |a Tamimi, Rulla M
|b 134
700 1 _ |a Taylor, Jack A
|b 135
700 1 _ |a Thöne, Kathrin
|b 136
700 1 _ |a Troester, Melissa A
|b 137
700 1 _ |a Truong, Thérèse
|b 138
700 1 _ |a Vachon, Celine M
|b 139
700 1 _ |a van Ongeval, Chantal
|b 140
700 1 _ |a van Veen, Elke M
|b 141
700 1 _ |a Wagner, Philippe
|b 142
700 1 _ |a Weinberg, Clarice R
|b 143
700 1 _ |a Wildiers, Hans
|b 144
700 1 _ |a Willett, Walter
|b 145
700 1 _ |a Winham, Stacey J
|b 146
700 1 _ |a Wolk, Alicja
|b 147
700 1 _ |a Yang, Xiaohong R
|b 148
700 1 _ |a Zheng, Wei
|b 149
700 1 _ |a Ziogas, Argyrios
|b 150
773 _ _ |a 10.1093/ije/dyz193
|g p. dyz193
|0 PERI:(DE-600)1494592-7
|n 1
|p 216-232
|t International journal of epidemiology
|v 49
|y 2020
|x 1464-3685
909 C O |p VDB
|o oai:inrepo02.dkfz.de:147186
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 72
|6 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 85
|6 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 86
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 124
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J EPIDEMIOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J EPIDEMIOL : 2017
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 3
920 1 _ |0 I:(DE-He78)B072-20160331
|k B072
|l B072 Molekulargenetik des Mammakarzinoms
|x 4
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 5
920 0 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)B072-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21